qtrly revenue $473 million versus refinitiv ibes estimate of $473.4 million.
qtrly same-store sales increased 1.3%.
sees q3 pediatric cardiology volume down slightly by 2%.
qtrly pediatric hospitalist volumes increased 11.5% compared to q2 of 2019.
qtrly net sales of $25 million included $7 million gain on sale.
qtrly total g&a increased $3 million to $4 million.
sees fy adjusted ebitda above $270 million.
expects to end 2021 with adjusted ebitda to be below 2.5 times higher than prior year.